AAAAAA
Results: 1-25/110
Authors:
BRADEN B
WENKE A
KARICH HJ
DIETRICH CF
SCHARRER I
CASPARY WF
LEMBCKE B
Citation: B. Braden et al., RISK OF GASTROINTESTINAL-BLEEDING ASSOCIATED WITH HELICOBACTER-PYLORIINFECTION IN PATIENTS WITH HEMOPHILIA OR VON-WILLEBRANDS-SYNDROME, Helicobacter (Cambridge, Mass.), 3(3), 1998, pp. 184-187
Authors:
NOBAUERHUHMANN IM
HOLLER W
KRINNINGER B
TURECEK PL
RICHTER G
SCHARRER I
FORBERG E
WATZKE HH
Citation: Im. Nobauerhuhmann et al., FACTOR-X FRANKFURT-I - MOLECULAR AND FUNCTIONAL-CHARACTERIZATION OF AHEREDITARY FACTOR-X DEFICIENCY (GLA(+25) TO LYS), Blood coagulation & fibrinolysis, 9(2), 1998, pp. 143-152
Authors:
EHRENFORTH S
ZWINGE B
SCHARRER I
Citation: S. Ehrenforth et al., HIGH PREVALENCE OF FACTOR-V R506Q MUTATION IN GERMAN THROMBOPHILIC AND NORMAL POPULATION, Thrombosis and haemostasis, 79(3), 1998, pp. 684-685
Authors:
VIELHABER H
EHRENFORTH S
KOCH HG
SCHARRER I
VANDERWERF N
NOWAKGOTTL U
Citation: H. Vielhaber et al., CEREBRAL VENOUS SINUS THROMBOSIS IN INFANCY AND CHILDHOOD - ROLE OF GENETIC AND ACQUIRED RISK-FACTORS OF THROMBOPHILIA, European journal of pediatrics, 157(7), 1998, pp. 555-560
Authors:
VELDMAN A
MARTIN H
FAUTH F
POTZSCH B
SCHARRER I
ETTINGSHAUSEN CE
HOELZER D
KREUZ W
GOETHE JW
Citation: A. Veldman et al., A NEW OPTION IN THE TREATMENT OF VOD AFTER BMT - CONTINUOUS-INFUSION OF RECOMBINANT TISSUE-PLASMINOGEN ACTIVATOR AND PROTEIN-C, Bone marrow transplantation, 21, 1998, pp. 834-834
Authors:
BECKER S
HELLER C
GROPP F
SCHARRER I
KREUZ W
Citation: S. Becker et al., THROMBOPHILIC DISORDERS IN CHILDREN WITH CEREBRAL INFARCTION, Lancet, 352(9142), 1998, pp. 1756-1757
Authors:
HATTENBACH LO
STEINKAMP G
SCHARRER I
OHRLOFF C
Citation: Lo. Hattenbach et al., FIBRINOLYTIC THERAPY WITH LOW-DOSE RECOMBINANT TISSUE-PLASMINOGEN ACTIVATOR IN RETINAL VEIN OCCLUSION, Ophthalmologica, 212(6), 1998, pp. 394-398
Authors:
FURLAN M
ROBLES R
GALBUSERA M
REMUZZI G
KYRLE PA
BRENNER B
KRAUSE M
SCHARRER I
AUMANN V
MITTLER U
SOLENTHALER M
LAMMLE B
Citation: M. Furlan et al., VON-WILLEBRAND FACTOR-CLEAVING PROTEASE IN THROMBOTIC THROMBOCYTOPENIC PURPURA AND THE HEMOLYTIC-UREMIC SYNDROME, The New England journal of medicine, 339(22), 1998, pp. 1578-1584
Authors:
SCHARRER I
KIRCHMAIER C
Citation: I. Scharrer et C. Kirchmaier, USE AND SAFETY OF BLOOD-PLASMA, Der Internist, 39(6), 1998, pp. 656-656
Authors:
CAMINADA MC
AHR A
SCHARRER I
SCHARL A
KAUFMANN M
Citation: Mc. Caminada et al., ACUTE EXACERBATED LUPUS-ERYTHEMATOSUS - D IFFERENTIAL-DIAGNOSIS OF A HELLP-SYNDROME, Geburtshilfe und Frauenheilkunde, 58(4), 1998, pp. 225-227
Authors:
EHRENFORTH S
LUDWIG G
KLINKE S
KRAUSE M
SCHARRER I
Citation: S. Ehrenforth et al., THE PROTHROMBIN-20210-A ALLELE IS FREQUENTLY COINHERITED IN YOUNG CARRIERS OF THE FACTOR-V ARG-506 TO GLN MUTATION WITH VENOUS THROMBOPHILIA, Blood, 91(6), 1998, pp. 2209-2210
Authors:
RUPPERT C
EHRENFORTH S
SCHARRER I
HALBERSTADT E
Citation: C. Ruppert et al., PROTEASE LEVELS IN BREAST, OVARY, AND OTHER GYNECOLOGICAL TUMOR-TISSUES - PROGNOSTIC IMPORTANCE IN BREAST-CANCER, Cancer detection and prevention, 21(5), 1997, pp. 452-459
Authors:
RADTKE KP
SCHARRER I
Citation: Kp. Radtke et I. Scharrer, FACTOR-V R506Q GENOTYPE DETERMINATION USING A SINGLE ALLELE-SPECIFIC PCR REACTION - DETECTION OF PCR PRODUCTS ON MICROTITER PLATES, Thrombosis and haemostasis, 1997, pp. 62-62
Authors:
PRONDZINSKI MV
BERGER A
SCHARRER I
BARTHELS M
Citation: Mv. Prondzinski et al., THE CLINICAL COURSE OF CHRONIC HEPATITIS IN HEMOPHILIACS WITH AND WITHOUT HIV-COINFECTION, Thrombosis and haemostasis, 1997, pp. 987-987
Authors:
KLINKE S
EHRENFORTH S
ZWINGE B
SCHARRER I
Citation: S. Klinke et al., ONSET OF THROMBOEMBOLIC DISEASE IN A LARGE NUMBER OF PATIENTS WITH HOMOZYGOUS FACTOR V-MUTATION, Thrombosis and haemostasis, 1997, pp. 1263-1263
HYPERHOMOCYSTEINAEMIC PATIENTS EXHIBIT INCREASED S-NITROSOTHIOL IN PLASMA AFTER METHIONINE CHALLENGE
Authors:
MULSCH A
MULLER N
SCHARRER I
Citation: A. Mulsch et al., HYPERHOMOCYSTEINAEMIC PATIENTS EXHIBIT INCREASED S-NITROSOTHIOL IN PLASMA AFTER METHIONINE CHALLENGE, Thrombosis and haemostasis, 1997, pp. 1607-1607
Authors:
HUHMANN I
TURECEK PL
RICHTER G
SCHARRER I
FORBERG E
WATZKE HH
Citation: I. Huhmann et al., FACTOR-X FRANKFURT-I - MOLECULAR CHARACTERIZATION AND IN-VITRO EXPRESSION OF A HEREDITARY FACTOR-X DEFECT (GLA+25 TO LYS), Thrombosis and haemostasis, 1997, pp. 1743-1743
Authors:
ARNDT S
SEWELL AC
EHRENFORTH S
WENKE A
SCHARRER I
BOHLES HJ
GOETHE JW
Citation: S. Arndt et al., HYPERHOMOCYSTEINEMIA IN JUVENILE VENOUS THROMBOSIS - METHIONINE INTOLERANCE AND VITAMIN SUPPLEMENTATION, Thrombosis and haemostasis, 1997, pp. 2172-2172
Authors:
MENTZER D
BURGSMULLER G
HELLER C
ANDRITSCHKE K
SCHARRER I
KREUZ W
Citation: D. Mentzer et al., SUFFICIENT INCREASE OF CLOTTING FACTORS AFTER REDUCED DDAVP TEST-DOSAGE IN VON-WILLEBRANDS-DISEASE TYPE-I, Thrombosis and haemostasis, 1997, pp. 2839-2839
Authors:
RINTELEN C
SCHARRER I
KLINKE S
MANNHALTER C
EICHINGER S
KYRLE PA
LECHNER K
PABINGER I
Citation: C. Rintelen et al., HIGH PREVALENCE OF STILLBIRTHS IN WOMEN HOMOZYGOUS FOR FACTOR-V-LEIDEN MUTATION, Thrombosis and haemostasis, 1997, pp. 3103-3103
Authors:
AYGORENPURSUN E
SCHARRER I
Citation: E. Aygorenpursun et I. Scharrer, A MULTICENTER PHARMACOSURVEILLANCE STUDY FOR THE EVALUATION OF THE EFFICACY AND SAFETY OF RECOMBINANT FACTOR-VIII IN THE TREATMENT OF PATIENTS WITH HEMOPHILIA-A, Thrombosis and haemostasis, 78(5), 1997, pp. 1352-1356
Authors:
WHITE GC
COURTER S
BRAY GL
LEE M
GOMPERTS ED
WHITE G
COOPER H
HAIRE W
BRETTLER D
KISKER T
HOOTS K
SHAPIRO A
HALIE MR
MANNUCCI PM
SCHARRER I
BRACKMANN HH
GORDON EM
GOLDSMITH J
HILGARTNER M
GILL J
LAURIAN Y
LARRIEU Y
KESSLER C
PAI MKR
LUSHER JM
NEUFELD E
EWENSTEIN B
SCHULMAN S
MORFINI M
ADDIEGO JE
VERMYLEN JG
KRILL CE
INGERSLEV J
Citation: Gc. White et al., A MULTICENTER STUDY OF RECOMBINANT FACTOR-VIII (RECOMBINATE(TM)) IN PREVIOUSLY TREATED PATIENTS WITH HEMOPHILIA-A, Thrombosis and haemostasis, 77(4), 1997, pp. 660-667
Authors:
NUBLING CM
BIALLECK H
FURSCH AJ
SCHARRER I
SCHRAMM W
SEIFRIED E
SCHMIDT U
STASZEWSKI S
LOWER J
Citation: Cm. Nubling et al., FREQUENCIES OF GB-VIRUS-C HEPATITIS-G VIRUS GENOMES AND OF SPECIFIC ANTIBODIES IN GERMAN RISK AND NON-RISK POPULATIONS, Journal of medical virology, 53(3), 1997, pp. 218-224
Authors:
BERGER A
DOERR HW
SCHARRER I
WEBER B
Citation: A. Berger et al., FOLLOW-UP OF 4 HIV-INFECTED INDIVIDUALS AFTER ADMINISTRATION OF HEPATITIS-C VIRUS AND GBV-C HEPATITIS-G VIRUS CONTAMINATED INTRAVENOUS IMMUNOGLOBULIN - EVIDENCE FOR HCV BUT NOT FOR GBV-C HGV TRANSMISSION/, Journal of medical virology, 53(1), 1997, pp. 25-30
Authors:
BERGER A
SCHARRER I
DOERR HW
HESS G
WEBER B
Citation: A. Berger et al., INFECTION WITH HEPATITIS-G VIRUS IN IMMUNOGLOBULIN RECIPIENTS, Lancet, 349(9046), 1997, pp. 207-207